Milestone Pharmaceuticals, Inc. (MIST)
1.14
-0.02
(-1.72%)
USD |
NASDAQ |
Sep 01, 13:48
Milestone Pharmaceuticals Cash from Investing (Quarterly) : 111.84M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 111.84M |
| March 31, 2026 | -80.03M |
| December 31, 2025 | 2.595M |
| September 30, 2025 | -35.62M |
| June 30, 2025 | 10.71M |
| March 31, 2025 | 33.58M |
| December 31, 2024 | 19.14M |
| September 30, 2024 | 6.40M |
| June 30, 2024 | 9.606M |
| March 31, 2024 | -27.01M |
| December 31, 2023 | 13.67M |
| September 30, 2023 | -10.90M |
| June 30, 2023 | -28.02M |
| March 31, 2023 | 29.97M |
| December 31, 2022 | -15.38M |
| Date | Value |
|---|---|
| September 30, 2022 | -16.43M |
| June 30, 2022 | -14.97M |
| March 31, 2022 | -8.00M |
| December 31, 2021 | 14.86M |
| September 30, 2021 | 22.26M |
| June 30, 2021 | 20.50M |
| March 31, 2021 | 12.00M |
| December 31, 2020 | -15.30M |
| September 30, 2020 | -25.22M |
| June 30, 2020 | -31.53M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 30.13M |
| September 30, 2019 | 4.366M |
| June 30, 2019 | -34.88M |
| March 31, 2019 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 0.00 |
| NervGen Pharma Corp. | -0.0001M |
| Clearmind Medicine, Inc. | -0.6541M |
| Lexaria Bioscience Corp. | -0.0271M |
| Target Group, Inc. (Canada) | -0.0065M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.53M |
| Cash from Financing (Quarterly) | 8.652M |
| Free Cash Flow | -61.10M |
| Free Cash Flow Per Share (Quarterly) | -0.1627 |
| Free Cash Flow to Equity (Quarterly) | -27.06M |
| Free Cash Flow to Firm (Quarterly) | -17.85M |
| Free Cash Flow Yield | -45.45% |